LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

LLY

1,063.79

-1.23%↓

JNJ

222.81

-0.32%↓

ABBV

215.58

+1.54%↑

UNH

377.18

-0.59%↓

MRK

115.96

+0.86%↑

Inicio・Lista de Acciones・NeoGenomics Inc

NeoGenomics Inc

Abierto

10.08 -3.54

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

9.94

Máximo

10.52

Métricas clave
By Trading Economics
Ingresos	-7.2M -17M
Ventas	-3.5M 187M
BPA	0.01
Margen de beneficios	-9.164
Empleados	2,500
EBITDA	-5.8M -567K

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+43.01% upside

Dividendos
By Dow Jones
Próximas Ganancias	28 jul 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	81M 1.2B
Apertura anterior	13.62
Cierre anterior	10.08

NeoGenomics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

1 jun 2026, 16:54 UTC

Charlas de Mercado

Correction to Hyperliquid Market Talk

1 jun 2026, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

1 jun 2026, 15:53 UTC

Charlas de Mercado

Hyperliquid Hits Record as ETFs Inflows Continue -- Market Talk

1 jun 2026, 15:17 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

1 jun 2026, 15:17 UTC

Charlas de Mercado

Late May Woes Look to Extend Into June for Crypto -- Market Talk

1 jun 2026, 14:47 UTC

Charlas de Mercado

Money in Bitcoin ETFs Keep Flowing Out -- Market Talk

1 jun 2026, 14:47 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

1 jun 2026, 14:42 UTC

Adquisiciones, fusiones, absorciones

Strategy Sells Bitcoin for First Time Since 2022. The Stock Is Sliding. -- Barrons.com

1 jun 2026, 13:58 UTC

Charlas de Mercado

Bitcoin Hits 7-Week Low After Report of Iran Halting Talks -- Market Talk

1 jun 2026, 13:27 UTC

Charlas de Mercado

News of Strategy Sale of BTC Pressures Crypto -- Market Talk

1 jun 2026, 11:42 UTC

Charlas de Mercado

Bitcoin Falls Amid Fears Over U.S.-Iran Conflict -- Market Talk

1 jun 2026, 07:07 UTC

Charlas de Mercado

Bitcoin Falls as U.S.-Iran Conflict Dents Risk Appetite -- Market Talk

29 may 2026, 18:10 UTC

Charlas de Mercado

As BTC Long-Term Holders Rise, Short-Term Holders Flee -- Market Talk

29 may 2026, 17:55 UTC

Charlas de Mercado

NEAR Protocol Nearly Doubles in May -- Market Talk

29 may 2026, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

29 may 2026, 15:55 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

29 may 2026, 15:55 UTC

Charlas de Mercado

Cryptocurrencies Appear Detached From Stocks -- Market Talk

29 may 2026, 15:40 UTC

Charlas de Mercado

Kalshi To Launch Crypto Perpetual Futures -- Market Talk

29 may 2026, 10:58 UTC

Charlas de Mercado

Signs of Weaker Risk Sentiment Evident in Bitcoin, Ethereum -- Market Talk

29 may 2026, 07:01 UTC

Charlas de Mercado

Bitcoin Recovers Only Slightly as U.S.-Iran Deal Remains Uncertain -- Market Talk

28 may 2026, 16:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

28 may 2026, 16:10 UTC

Charlas de Mercado

Key BTC Level Still Seen at $80k -- Market Talk

28 may 2026, 15:01 UTC

Charlas de Mercado

Bitcoin ETFs Speed Up Outflows -- Market Talk

28 may 2026, 14:36 UTC

Charlas de Mercado

Bitcoin Losses Accelerate Following April PCE Report -- Market Talk

28 may 2026, 06:54 UTC

Charlas de Mercado

Bitcoin Falls as U.S.-Iran Strikes Damp Risk Appetite -- Market Talk

28 may 2026, 06:54 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

28 may 2026, 06:54 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

28 may 2026, 02:51 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

28 may 2026, 02:51 UTC

Charlas de Mercado

Bitcoin Slips Amid Renewed U.S.-Iran Tensions -- Market Talk

27 may 2026, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

Comparación entre iguales

Cambio de precio

NeoGenomics Inc previsión

Precio Objetivo

By TipRanks

43.01% repunte

Estimación a 12 Meses

Media 14.93 USD 43.01%

Máximo 25 USD

Mínimo 11 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para NeoGenomics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

10 ratings

Comprar

Mantener

Vender

De acuerdo con 10 analistas que ofrecen calificaciones bursátiles a para NeoGenomics Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.